• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞外 miRNA 的前列腺癌诊断系统开发的数据分析算法。

Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.

机构信息

The Laboratory of Molecular Medicine, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

The Laboratory of Biomedical Technologies, Centre of New Medical Technologies,"E. Meshalkin National Medical Research Center" of the Ministry of Health of the Russian Federation, Novosibirsk, Russia.

出版信息

PLoS One. 2019 Apr 10;14(4):e0215003. doi: 10.1371/journal.pone.0215003. eCollection 2019.

DOI:10.1371/journal.pone.0215003
PMID:30970027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6457524/
Abstract

Urine of prostate cancer (PCa) carries miRNAs originated from prostate cancer cells as a part of both nucleoprotein complexes and cell-secreted extracellular vesicles. The analysis of such miRNA-markers in urine can be a convenient option for PCa screening. The aims of this study were to reveal miRNA-markers of PCa in urine and design a robust and precise diagnostic test, based on miRNA expression analysis. The expression analysis of the 84 miRNAs in paired urine extracellular vesicles (EVs) and cell free urine supernatant samples from healthy donors, patients with benign and malignant prostate tumours was done using miRCURY LNA miRNA qPCR Panels (Exiqon, Denmark). Sets of miRNAs differentially expressed between the donor groups were found in urine EVs and urine supernatant. Diagnostically significant miRNAs were selected and algorithm of data analysis, based on expression data on 24-miRNA in urine and obtained using 17 analytical systems, was designed. The developed algorithm of data analysis describes a series of steps necessary to define cut-off values and sequentially analyze miRNA expression data according to the cut-offs to facilitate classification of subjects in case/control groups and allows to detect PCa patients with 97.5% accuracy.

摘要

前列腺癌(PCa)尿液携带有源自前列腺癌细胞的 miRNA,作为核蛋白复合物和细胞分泌的细胞外囊泡的一部分。对尿液中此类 miRNA 标志物的分析可能是 PCa 筛查的一种便捷选择。本研究旨在揭示尿液中 PCa 的 miRNA 标志物,并基于 miRNA 表达分析设计一种强大而精确的诊断测试。使用 miRCURY LNA miRNA qPCR 面板(丹麦 Exiqon)对来自健康供体、良性和恶性前列腺肿瘤患者的配对尿细胞外囊泡(EVs)和无细胞尿上清样本中的 84 个 miRNA 的表达进行了分析。在尿 EVs 和尿上清中发现了供体组之间差异表达的 miRNA 集。选择具有诊断意义的 miRNA,并基于在尿中使用 17 个分析系统获得的 24 个 miRNA 的表达数据设计数据分析算法。开发的数据分析算法描述了根据截止值对 miRNA 表达数据进行连续分析以对病例/对照组进行分类的必要步骤,并允许以 97.5%的准确度检测 PCa 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/f9e627a16120/pone.0215003.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/6bc5d1f45e47/pone.0215003.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/464d95b7e06f/pone.0215003.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/b7c6ed98e8d4/pone.0215003.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/f9e627a16120/pone.0215003.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/6bc5d1f45e47/pone.0215003.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/464d95b7e06f/pone.0215003.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/b7c6ed98e8d4/pone.0215003.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9528/6457524/f9e627a16120/pone.0215003.g004.jpg

相似文献

1
Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.基于细胞外 miRNA 的前列腺癌诊断系统开发的数据分析算法。
PLoS One. 2019 Apr 10;14(4):e0215003. doi: 10.1371/journal.pone.0215003. eCollection 2019.
2
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
3
Detection of miRNAs in urine of prostate cancer patients.前列腺癌患者尿液中微小RNA的检测
Medicina (Kaunas). 2016;52(2):116-24. doi: 10.1016/j.medici.2016.02.007. Epub 2016 Mar 11.
4
Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.通过测量尿液细胞外囊泡中的微小RNA变体(异源微小RNA)进行非侵入性前列腺癌检测。
Oncotarget. 2016 Apr 19;7(16):22566-78. doi: 10.18632/oncotarget.8124.
5
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.尿细胞外囊泡来源的 miR-126-3p 预测高危前列腺癌患者的淋巴结侵犯。
Med Oncol. 2024 Jun 5;41(7):169. doi: 10.1007/s12032-024-02400-x.
6
Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia.全尿外泌体 RNA 区分前列腺癌与前列腺增生。
Int J Mol Sci. 2024 Sep 19;25(18):10079. doi: 10.3390/ijms251810079.
7
Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.亲和捕获尿液细胞外囊泡为提高前列腺癌检测准确性提供 mRNA 和 miRNA 生物标志物:一项初步研究。
Int J Mol Sci. 2020 Nov 6;21(21):8330. doi: 10.3390/ijms21218330.
8
Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression.在尿液中寻找前列腺癌的新型特异性预测因子:84 种 miRNA 表达分析。
Int J Mol Sci. 2018 Dec 17;19(12):4088. doi: 10.3390/ijms19124088.
9
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.细胞游离尿液中用于前列腺癌的诊断和预后的 microRNA 生物标志物。
Eur Urol Focus. 2018 Dec;4(6):825-833. doi: 10.1016/j.euf.2017.02.018. Epub 2017 Mar 9.
10
Identification of cell-free microRNAs in the urine of patients with prostate cancer.前列腺癌患者尿液中游离微小RNA的鉴定。
Urol Oncol. 2015 Jan;33(1):16.e17-16.e22. doi: 10.1016/j.urolonc.2014.09.015. Epub 2014 Oct 23.

引用本文的文献

1
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response.前列腺癌中的外泌体液体活检:诊断、预后和治疗反应生物标志物的系统评价
Int J Mol Sci. 2025 Jan 18;26(2):802. doi: 10.3390/ijms26020802.
2
Recent progress in microRNA research for prostate cancer.前列腺癌微小RNA研究的最新进展
Discov Oncol. 2024 Sep 27;15(1):480. doi: 10.1007/s12672-024-01376-4.
3
Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers.尿细胞外囊泡微小RNA——前列腺癌生物标志物的新时代。

本文引用的文献

1
The 24th Annual Prostate Cancer Foundation scientific retreat report.第24届前列腺癌基金会年度科学务虚会报告
Prostate. 2018 Sep;78(12):867-878. doi: 10.1002/pros.23651. Epub 2018 May 15.
2
Men with a susceptibility to prostate cancer and the role of genetic based screening.易患前列腺癌的男性以及基于基因的筛查的作用。
Transl Androl Urol. 2018 Feb;7(1):61-69. doi: 10.21037/tau.2017.12.30.
3
Prostate Cancer: Improving the Flow of Research.前列腺癌:改善研究流程。
Front Genet. 2023 Jan 20;14:1065757. doi: 10.3389/fgene.2023.1065757. eCollection 2023.
4
Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update.尿微小RNA及其在前列腺癌诊断中的意义:五年进展
Cancers (Basel). 2022 Jun 28;14(13):3157. doi: 10.3390/cancers14133157.
5
MicroRNAs as Potential Liquid Biopsy Biomarker for Patients with Castration-Resistant Prostate Cancer.微小RNA作为去势抵抗性前列腺癌患者潜在的液体活检生物标志物
Res Rep Urol. 2022 Mar 1;14:63-70. doi: 10.2147/RRU.S332578. eCollection 2022.
6
Nanomaterials-Based Urinary Extracellular Vesicles Isolation and Detection for Non-invasive Auxiliary Diagnosis of Prostate Cancer.基于纳米材料的尿液细胞外囊泡分离与检测用于前列腺癌的无创辅助诊断
Front Med (Lausanne). 2022 Jan 14;8:800889. doi: 10.3389/fmed.2021.800889. eCollection 2021.
7
Locus-Specific Methylation of GSTP1, RNF219, and KIAA1539 Genes with Single Molecule Resolution in Cell-Free DNA from Healthy Donors and Prostate Tumor Patients: Application in Diagnostics.健康供体和前列腺肿瘤患者游离DNA中GSTP1、RNF219和KIAA1539基因位点特异性甲基化的单分子分辨率研究:在诊断中的应用
Cancers (Basel). 2021 Dec 12;13(24):6234. doi: 10.3390/cancers13246234.
8
Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances.尿细胞外囊泡作为泌尿系统癌症的潜在生物标志物:当前方法与进展概述
Cancers (Basel). 2021 Mar 26;13(7):1529. doi: 10.3390/cancers13071529.
9
The Influence of Radical Prostatectomy on the Expression of Cell-Free MiRNA.根治性前列腺切除术对游离微小RNA表达的影响
Diagnostics (Basel). 2020 Aug 17;10(8):600. doi: 10.3390/diagnostics10080600.
10
The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms.作为前列腺肿瘤潜在生物标志物的12种无细胞微小RNA检测组
Diagnostics (Basel). 2020 Jan 10;10(1):38. doi: 10.3390/diagnostics10010038.
Radiology. 2018 Apr;287(1):5-9. doi: 10.1148/radiol.2018171046.
4
Genetic markers a landscape in prostate cancer.遗传标记物——前列腺癌研究的全景图
Mutat Res Rev Mutat Res. 2018 Jan-Mar;775:1-10. doi: 10.1016/j.mrrev.2017.11.004. Epub 2017 Nov 29.
5
[Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms].[前列腺恶性肿瘤和非恶性肿瘤中澄清尿液及尿液微泡中miRNA的表达分析]
Biomed Khim. 2018 Jan;64(1):38-45. doi: 10.18097/PBMC20186401038.
6
MicroRNA expression profiles in benign prostatic hyperplasia.良性前列腺增生中的 microRNA 表达谱。
Mol Med Rep. 2018 Mar;17(3):3853-3858. doi: 10.3892/mmr.2017.8318. Epub 2017 Dec 19.
7
Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.循环 miRNA 的检测:前列腺癌患者全血浆中外泌体结合 miRNA 和无细胞游离 miRNA 的比较分析。
BMC Cancer. 2017 Nov 9;17(1):730. doi: 10.1186/s12885-017-3737-z.
8
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.通过对尿液外泌体的深度测序分析鉴定前列腺癌的非侵入性 miRNA 生物标志物。
Mol Cancer. 2017 Oct 5;16(1):156. doi: 10.1186/s12943-017-0726-4.
9
Urinary biomarkers in prostate cancer detection and monitoring progression.用于前列腺癌检测和监测病情进展的尿液生物标志物。
Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19.
10
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.循环mRNA和miRNA作为前列腺癌诊断和预后的候选标志物。
PLoS One. 2017 Sep 14;12(9):e0184094. doi: 10.1371/journal.pone.0184094. eCollection 2017.